Skip to main content
. Author manuscript; available in PMC: 2014 Jan 28.
Published in final edited form as: Int J Immunopathol Pharmacol. 2011 Jul-Sep;24(3):595–601. doi: 10.1177/039463201102400305

Fig. 3.

Fig. 3

Gene expression in the fibroblasts with and without siRNA transfection. Comparison of gene expression with Ctgf siRNA. Sparc siRNA, or Non-Targeting siRNA treatment in wide type (A) and Colla2-CTGF transgenic mice fibroblasts (B), respectively. The expression level of each gene in each fibroblast line with Non-Targeting siRNA treatment was normalized to 1. Assays were performed in triplicates. * P < 0.05.